Evidence map›Paper›PMID 31522250›Full record

ReviewCellular and molecular life sciences : CMLS2020

Auditory function and dysfunction: estrogen makes a difference.

Amandine Delhez, Philippe Lefebvre, Christel Péqueux, Brigitte Malgrange, Laurence Delacroix

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 4 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 4 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Prevalence of Hearing Loss After Open-Heart Surgery: A Systematic Review.Brazilian journal of cardiovascular surgery · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Burden and causes of hearing loss among different genders and ages in China: a secondary analysis of the 2019 global burden of disease study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  6. Review
  7. Association of Menopause and Hormone Replacement Therapy with Hearing Loss.The Annals of otology, rhinology, and laryngology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Amandine DelhezGIGA-Neurosciences, Developmental Neurobiology Unit, University of Liege, Liege, Belgium.
Philippe LefebvreDepartment of ENT, CHU de Liege, Liege, Belgium.
Christel PéqueuxGIGA-Cancer, Laboratory of Tumors Biology and Development, University of Liege, Liege, Belgium.
Brigitte MalgrangeGIGA-Neurosciences, Developmental Neurobiology Unit, University of Liege, Liege, Belgium.
Laurence DelacroixGIGA-Neurosciences, Developmental Neurobiology Unit, University of Liege, Liege, Belgium. ldelacroix@uliege.be.ORCID http://orcid.org/0000-0003-3440-5359
University of Liège · BECentre Hospitalier Universitaire de Liège · BE

Funding

Fonds Léon Fredericq Bourse FLF2018
6 · The paper itself

Abstract

Estrogen is the major female hormone involved in reproductive functions, but it also exerts a variety of additional roles in non-reproductive organs. In this review, we highlight the preclinical and clinical studies that have pointed out sex differences and estrogenic influence on audition. We also describe the experimental evidences supporting a protective role of estrogen towards acquired forms of hearing loss. Although a high level of endogenous estrogen is associated with a better hearing function, hormonal treatments at menopause have provided contradictory outcomes. The various factors that are likely to explain these discrepancies include the treatment regimen as well as the hormonal status and responsiveness of the patients. The complexity of estrogen signaling is being untangled and many downstream effectors of its genomic and non-genomic actions have been identified in other systems. Based on these advances and on the common physio-pathological events that underlie age-related, drug or noise-induced hearing loss, we discuss potential mechanisms for their protective actions in the cochlea.

Indexed as

HearingAnimalsCochleaDeafnessEstrogensFemaleHumansMaleReceptors, EstrogenSex CharacteristicsSex FactorsSignal TransductionEstrogensReceptors, EstrogenCochleaDeafnessEstradiolNeuroprotectionOtoprotectionSexual dimorphismSteroid

Identifiers

PMID31522250
PMCPMC11105012
OpenAlexW2973155512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.